 |
|
EDAP TMS S.A.
(NASDAQ:EDAP and NASDAQ EUROPE: :EDAP) -- EDAP Technomed -- develops, produces,
markets and distributes a portfolio of minimally invasive medical devices,
primarily for the treatment of urological diseases. The company is committed to
improving the quality of patient care and the productivity of healthcare
organization through the development of new technologies and the supply of new
medical devices and procedures that are intended to provide simpler, less
traumatic, less costly and more efficient means of treatment and diagnosis.
|
|
